Everyday Oral Surgery Hematology Series – Leukemia Types, Diagnosis, and Treatment Modalities (with Drs. Andrew Jenzer and Maxwell Lloyd)
Aug 11, 2025
Dr. Andrew Jenzer, a facial surgeon from North Carolina, and Dr. Maxwell Lloyd, a hematology oncology specialist from Boston, dive into the intricate world of leukemia. They explore various leukemia types, including acute myeloid and chronic lymphocytic leukemia, shedding light on symptoms and diagnostic strategies. The guests discuss the impact of chemotherapy on oral surgery and the nuances of different treatment modalities. With insights into leukocytosis and innovative treatment approaches, this conversation is a must-listen for anyone interested in hematology.
AI Snips
Chapters
Transcript
Episode notes
Watch Blast Percent Over Total WBC
- Blast percentage often predicts leukostasis risk more than absolute white blood cell count.
- Track serial CBCs to gauge disease tempo and act quickly if blasts climb fast.
Transplant Versus Risk Drives AML Plans
- AML care hinges on two decisions: transplant fitness and disease risk classification.
- These determine whether you pursue induction then consolidation with curative intent or palliative regimens.
HMA Plus Venetoclax Revolutionized AML
- Combining a hypomethylating agent (azacitidine/dacitabine) with venetoclax changed treatment for older or unfit AML patients.
- This regimen improved survival and offered a tolerable alternative to intensive chemo.